Multiple Myeloma: evidence-based decision making using randomized controlled trials

Chrissy Tan; Chrissy Tan

Multiple Myeloma: evidence-based decision making using randomized controlled trials

Chrissy Tan, Chrissy Tan

Research output: Types of Thesis › Doctoral Thesis › Internal

143 Downloads (Pure)

Abstract

This dissertation describes how phase 3 randomised control trial data can be utilized to support evidence-based decision making for determining the cost-effectiveness of treatment sequences in multiple myeloma. It also emphasizes that health technology assessment agencies must be aware of different methods of data synthesis, which result in slightly different rankings of treatments.

Original language	English
Awarding Institution	Erasmus University Rotterdam
Supervisors/Advisors	Sonneveld, Pieter, Supervisor de Groot, Carin, Supervisor
Award date	11 Oct 2022
Place of Publication	Rotterdam
Print ISBNs	978-94-6361-731-4
Publication status	Published - 11 Oct 2022

Access to Document

final dissertation Beurden-Tan, ChrissyFinal published version, 62.5 MB
embargo version Beurden-Tan, ChrissyOther version, 58.7 MB

Cite this

@phdthesis{d48c92ac700249faa81b0fc1f9e295cd,

title = "Multiple Myeloma: evidence-based decision making using randomized controlled trials",

abstract = "This dissertation describes how phase 3 randomised control trial data can be utilized to support evidence-based decision making for determining the cost-effectiveness of treatment sequences in multiple myeloma. It also emphasizes that health technology assessment agencies must be aware of different methods of data synthesis, which result in slightly different rankings of treatments.",

author = "Chrissy Tan and Chrissy Tan",

year = "2022",

month = oct,

day = "11",

language = "English",

isbn = "978-94-6361-731-4",

school = "Erasmus University Rotterdam",

}

TY - BOOK

T1 - Multiple Myeloma

T2 - evidence-based decision making using randomized controlled trials

AU - Tan, Chrissy

PY - 2022/10/11

Y1 - 2022/10/11

N2 - This dissertation describes how phase 3 randomised control trial data can be utilized to support evidence-based decision making for determining the cost-effectiveness of treatment sequences in multiple myeloma. It also emphasizes that health technology assessment agencies must be aware of different methods of data synthesis, which result in slightly different rankings of treatments.

AB - This dissertation describes how phase 3 randomised control trial data can be utilized to support evidence-based decision making for determining the cost-effectiveness of treatment sequences in multiple myeloma. It also emphasizes that health technology assessment agencies must be aware of different methods of data synthesis, which result in slightly different rankings of treatments.

M3 - Doctoral Thesis

SN - 978-94-6361-731-4

CY - Rotterdam

ER -

Multiple Myeloma: evidence-based decision making using randomized controlled trials

Abstract

Access to Document

Other files and links

Fingerprint

Cite this